Results of Open Offer

RNS Number : 1769K

Medaphor Group PLC

12 December 2018

 

The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

MedaPhor Group plc

("MedaPhor" or the "Company")

Results of Open Offer

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that further to the announcement of the Placing and Open Offer on 26 November 2018, it has conditionally raised total gross proceeds of £78,778 via the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 11 December 2018. The Company received valid acceptances from Qualifying Shareholders in respect of 926,801 Open Offer Shares, including applications for 63,354 Open Offer Shares under the Excess Application Facility. This represents 3.8 per cent. of the maximum Open Offer Shares available under the Open Offer. Admission of the Open Offer shares is subject to passing the relevant resolutions at the General Meeting.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 26 November 2018.

Enquiries:

MedaPhor Group plc	www.medaphor.com
Stuart Gall, CEO  Wilson Jennings, CFO	Tel: [phone]
Cenkos Securities - Nominated Advisor and broker	Tel:  [phone]
Mark Connelly / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR	Tel: [phone] or [e-mail]
Anna Dunphy / Paul McManus	Mob: [phone] / Mob: [phone]

 

END

 

 

ROIEANAFFLDPFFF